In the mid-90s, Ms. Kimmie Mathews developed effective formulas in the form of topical treatments and nutritional supplements for her own 2nd-3rd degree burns. Subsequently, she wanted to share her expertise and products with other burn victims. This eventually led her to Mr. Bernard Armani, a managing partner, who at that time had moved from his native Germany to start his first company, DermaMed Pharmaceuticals in Canada. It was nearly 20 years ago they first met and since then, they have continued to come together.
Ms. Mathews is a successful lecturer and researcher in the Cosmeceutical and Nutraceutical fields. One of her signature products in her cell regenerative line is a well-known nutritive hydrating serum, RG-Cell. She has also developed a number of products for specific clients, primarily medical doctors as well as private companies. As a master formulator, using blue green algae as a base ingredient, Ms. Mathews has created a broad range of OEM and ODM product lines, including Klamath Beauty, Bellini, Symbio-GBK (health/skin care), Functional Organic Tooth Paste, as well as many other nutritional and probiotic products.
Ms. Mathews as the company’s President & CEO, and Mr. Armani as the company’s managing partner, agree to execute all their means to support the Panacea World Health Network, with the core-valued technologies within each subsidiary, and their total grand accumulated experience from the attainments of both parties in managing, operating, and marketing in their combined capacity.
Mr. Armani is the founder of several successful companies, including Eidam Diagnostics Corporation, Biolytical Laboratories Inc., Deserving Health Group and Panacea Preventive Medicine Clinic & Research Centre. Additionally, he has an extensive background in the engineering of botanical extractions and in drug development, with copyright and intellectual properties in Spagyrik tinctures, and with Pleomorphic and Isopathic remedies comprising part of his portfolio.
Mr. Armani also developed the most advanced In Vitro Diagnostic Rapid Testing Technology. His state-of-the-art detection devices include: BioIQ-Test, Rapid Test Kit for infectious diseases such as Hepatitis C, Syphilis, HIV, and others. He has been expanding his business in bio-industry and has invested in new biotechnology.
Mr. Armani has successfully established a holding company called Platinum 21 Holdings Corporation (Richmond, British Columbia, Canada) with its subsidiaries. He combined forces with Ms. Mathews to establish a new entity, Panacea World Health Network (PWHN). As Managing Director and Shareholder in Platinum 21 Holdings Corporation, Ms. Mathews works directly with Mr. Armani to share whatsoever they possess, and to use their combined resources in reaching out to provide help to people of all ages who are experiencing extreme hunger and suffering, such as war refugees, worldwide.
(+1) 604 209 5085
Dr. Kim, James is a young scientist from the Republic of Korea who believes the future of scientific technology should include standing up for the future of mankind, and it should be led by the younger generation.
He obtained a BS in Biological and Chemical Engineering from the Chonnam National University (CNU) in Korea, and a MS in Proteomics from CNU medical school.
During his MS, the Korea Ministry of Health and Welfare R&D Project supported his research and he participated in patenting biomarkers related to Acute Myeloid Leukemia.
Before his Ph.D., he spent several years in the CNU Medical Research Centre and CNU Hospital Biomedical Research Institute to research Cancer & Cell Biology. He then studied Pharmacokinetics and Pharmacodynamics at the CNU Hospital and obtained his Ph.D. in Pharmacometrics.
He has also experienced and learned about clinical trials in research projects supported by a grant from the Health Technology R&D Project of the Ministry of Health & Welfare in Korea.
Dr. Kim, James is an excellent laboratory technician and has the ability to combine the expertise of the various fields he has studied and in which he has participated. He has earned awards from academic conferences in the Korean Human Proteome Organisation, the Korean Society for Anaesthetic Pharmacology, and the CNU Medical Research Centre.
Dr. Kim, James has been working for a cosmeceutical and nutraceutical company in Korea, and has consulted with several companies in the Korea health industry. In addition, he now is working on research using primitive bacteria. He is also participating in the area of alternative medicine research and he participated in patenting biomarkers related to Acute Myeloid Leukemia.